Georgina Baker appointed Chair of the International Finance Facility for Immunisation Board
Georgina Baker appointed Chair of the International Finance Facility for Immunisation Board
22 October 2025
Georgina Baker
London, 22 October 2025 – The International Finance Facility for Immunisation (IFFIm) today announced the appointment of Georgina Baker as Chair of its Board of Directors, effective 1 January 2026. Ms Baker succeeds Ken Lay, who has led the Board since 2021 and will continue to serve as a Director through 2026 to ensure a smooth transition and continuity of leadership.
Ms Baker, a seasoned global finance executive, brings extensive experience in innovative financing and capital markets. Over her distinguished career, including senior leadership roles at the International Finance Corporation (IFC), she has championed private sector solutions to address critical development challenges. Her expertise in emerging markets, structured finance and sustainable development financing aligns closely with IFFIm’s mission to mobilise resources for Gavi, the Vaccine Alliance, to accelerate equitable access to life-saving vaccines.
“Georgina’s deep understanding of capital markets and her commitment to global health make her highly qualified to lead IFFIm,” said Sania Nishtar, CEO of Gavi, the Vaccine Alliance. “Georgina’s leadership will enhance IFFIm’s ability to provide the flexible, rapid funding that will be more critical than ever as Gavi transitions to new ways of working, through the Gavi Leap, in its upcoming sixth five-year strategy.”
Ms Baker expressed her enthusiasm for the new role. “IFFIm is a proven innovator in development finance, and I am honoured to serve as its next Board Chair. Together with my fellow Directors and partners, I look forward to continuing IFFIm’s critical work of ensuring that every child, everywhere, has access to life-saving vaccines.”
“Serving as Chair of IFFIm’s Board since 2021 has been an extraordinary experience, and I am proud of all we have accomplished together over the past five years,” said Ken Lay. “Georgina’s appointment is excellent news for IFFIm and for Gavi’s mission. I look forward to working with her and the Board in the coming year to continue building on our success.”
IFFIm uses long-term pledges from 11 sovereign donors, securitised through the capital markets, to provide immediate funding for Gavi’s immunisation programmes. Since its launch in 2006, IFFIm has contributed more than US$ 6.2 billion to Gavi, accelerating vaccine delivery to more than 1.2 billion children in the world’s poorest countries and saving 20.6 million lives.
For more information about IFFIm and its Board of Directors, click here.
Share this article
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.